Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2011; 17(30): 3497-3502
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3497
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3497
Table 2 Characteristics of treatment in the 38 patients according to the stage of pancreatic cancer
Metastatic | Locally advanced | |
Number of patients treated by gemcitabine-based chemotherapy (%) | 15 (50%) | 15 (50%) |
Number of patients with BSC on first intention | 5 | 3 |
-staff decision ECO ≥ 2 | 3 | 2 |
-others reasons | 2 (Septicaemia, pulmonary embolism) | 1 (Duodenal stenosis and deep venous thrombosis) |
Median number of infusions (range)1 | n = 18 | n = 7 |
(1-45) | (2-13) |
- Citation: Hentic O, Dreyer C, Rebours V, Zappa M, Lévy P, Raymond E, Ruszniewski P, Hammel P. Gemcitabine in elderly patients with advanced pancreatic cancer. World J Gastroenterol 2011; 17(30): 3497-3502
- URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3497.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3497